SOUTH SAN FRANCISCO, CA, January 5, 2026 – Electra Therapeutics, a clinical stage biotechnology company pioneering therapies against novel targets for diseases in immunology and cancer, today announced that it will present at the 44 th annual J.P. Morgan…